The fish vaccines market is likely to register a CAGR of 6.5% during the forecast period, and is anticipated to reach a market share of US$ 0.4 Bn in 2032, from US$ 0.2 Bn in 2021, owing to increasing survival rate and high production of fish in large scale commercial production of fish.
| Attributes | Details |
| Fish Vaccines Market CAGR | 6.5% |
| Fish Vaccines Market Size (2032) | US$ 0.4 Bn |
| Fish Vaccines Market Size (2021) | US$ 0.2 Bn |
Due to the increasing number of aquaculture farms and the quick development of new vaccines, the demand for fish vaccines is booming. Aside from that, advances in technology and the development of innovative adjuvants have boosted the sales of fish vaccines.
Moreover, marker vaccines, novel expression systems, passive immunization, immunostimulants, enhanced DNA vaccines, and adjuvants are some of the upcoming components for rise in demand for fish vaccines that will likely accelerate the expansion of the fish vaccines market share. Most commercially available vaccinations are currently inactivated.
For fish immunizations, injectable vaccines with adjuvants are commonly utilized. Antibiotic usage has been reduced to the bare minimum in order to ensure long-term biological production, driving the demand for fish vaccines, hence the global fish vaccines market is ripe for expansion.
According to the United Nations' Food and Agriculture Organization, global fish production in 2016 was estimated to be 171 million tonnes, with aquaculture accounting for 47% of total production and 53% for non-food uses. With the increase in fish production, the sales of fish vaccines is expected to develop significantly in the future years.
Due to the increased survival rate and high production of fish in large-scale commercial fish farming, demand for fish vaccines is seeing exponential expansion. Aside from that, the fish vaccines market will rise due to the growing number of aquaculture sectors.
Furthermore, fish vaccines are cost-effective and give a long-lasting preventive impact on the fish, resulting in increased immunity and fish production, leading to the sales of fish vaccines.
Fish vaccinations, on the other hand, have some limitations. The fish vaccines market share may be impacted by the production of cost-effective antigens and adjuvants that confront environmental and regulatory constraints. This hampers the sales of fish vaccines.
Apart from that, the sales of fish vaccines will be hampered by the necessity for highly skilled workers to inject the vaccine, as well as major handling issues and the risk of fungal infections.
The global fish vaccines market is divided into seven primary regions based on geography: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, and the Middle East and Africa.
Due to the region's rising aquaculture industry and increased research and development in developing innovative adjuvants for fish vaccines, North America is expected to hold a substantial fish vaccines market share.
Due to the region's enormous fish production and expanding number of aquaculture farms, the demand for fish vaccines in Europe is experiencing significant expansion. The sales of fish vaccines in Asia Pacific also has a lot of potential, thanks to the region's growing economy and population, as well as the region's high fish consumption.
Due to a lack of competent workers in fish vaccines and a paucity of veterinary vaccines, the Middle East and Africa has a comparatively low demand for fish vaccines.
Syndel USA, PHARMAQ, CZ Vaccines, Lumic A/S, MSD Animal Health, Marrinovak Ltd, and Anicon Labor GmbH are some of the main companies in the global fish vaccines market, holding a substantial fish vaccines market share.
| Report Attribute | Details |
| Growth rate | CAGR of 6.5% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 - 2020 |
| Forecast period | 2022 - 2032 |
| Quantitative units | Revenue in USD billion, volume in kilotons, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Vaccine type, distribution channel, region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | Syndel USA, PHARMAQ, CZ Vaccines, Lumic A/S, MSD Animal Health, Marrinovak Ltd, and Anicon Labor GmbH |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
The fish vaccines market is anticipated to register a CAGR of 6.5% during the forecast period.
The fish vaccines market share is anticipated to reach US$ 0.4 Bn by 2032.
Demand for fish vaccines is likely to rise, owing to increasing survival rate and high production of fish in large scale commercial production of fish.
Explore Similar Insights
Fish Vaccines Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
